AIMC Topic: Immunomodulating Agents

Clear Filters Showing 1 to 2 of 2 articles

Machine Learning-Enhanced Single-Particle Tracking for Rapid Screening of Tumor Immunomodulatory Drugs.

ACS nano Jul 21, 2025
The tumor microenvironment plays a critical role in tumor progression and immune response, with the extracellular matrix (ECM) regulating immune cell infiltration. However, the interplay between ECM dynamics and tumor immunity remains poorly understo...
Humans Machine Learning Tumor Microenvironment Animals Neoplasms Antineoplastic Agents Cell Line, Tumor Mice Drug Screening Assays, Antitumor Quantum Dots Extracellular Matrix Immunomodulating Agents
View on PubMed DOI

Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US health-care system.

The Lancet. Digital health May 1, 2024
BACKGROUND: In the context of immune-mediated inflammatory diseases (IMIDs), COVID-19 outcomes are incompletely understood and vary considerably depending on the patient population studied. We aimed to analyse severe COVID-19 outcomes and to investig...
Humans Machine Learning COVID-19 Retrospective Studies Female SARS-CoV-2 Risk Factors Hospitalization Aged Adult Male Middle Aged Comorbidity COVID-19 Vaccines United States Immunomodulating Agents
View on PubMed DOI
Popular Topics
Recent Journals